Trial Profile
Phase II study of doxercalciferol for the treatment of myelodysplastic syndromes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2019
Price :
$35
*
At a glance
- Drugs Doxercalciferol (Primary)
- Indications Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 25 Sep 2005 New trial record.